Earnings Feed
Start Free
Home/Filings/4/0000899243-21-007412
4//SEC Filing

Versant Side Fund IV, L.P. 4

Accession 0000899243-21-007412

CIK 0001720725other
View on SEC.govCompany Profile

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 5:16 PM ET

Size

32.8 KB

Accession

0000899243-21-007412

Insider Transaction Report

Form 4
Period: 2021-02-17
Oyster Point Pharma, Inc.OYST
Versant Venture Capital VI, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-02-17−325,000→ 2,236,888 total
  • Other

    Common Stock

    2021-02-17+6,500→ 6,500 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17+5,607→ 5,607 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−6,500→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−5,607→ 0 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    2,002,298

  • Common Stock

    (indirect: See Footnotes)
    1,003,658

  • Common Stock

    (indirect: See Footnotes)
    12,438
Versant Ventures VI GP, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-02-17−325,000→ 2,236,888 total
  • Other

    Common Stock

    2021-02-17+6,500→ 6,500 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−6,500→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17+5,607→ 5,607 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−5,607→ 0 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    2,002,298

  • Common Stock

    (indirect: See Footnotes)
    12,438

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Ventures IV, LLC
10% Owner
Transactions
  • Other

    Common Stock

    2021-02-17+5,607→ 5,607 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−5,607→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−325,000→ 2,236,888 total
  • Other

    Common Stock

    2021-02-17+6,500→ 6,500 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−6,500→ 0 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    2,002,298

  • Common Stock

    (indirect: See Footnotes)
    12,438

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Venture Capital IV, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-02-17−325,000→ 2,236,888 total
  • Other

    Common Stock

    2021-02-17+6,500→ 6,500 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−6,500→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17+5,607→ 5,607 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−5,607→ 0 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    2,002,298

  • Common Stock

    (indirect: See Footnotes)
    12,438

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Side Fund IV, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-02-17−325,000→ 2,236,888 total
  • Other

    Common Stock

    2021-02-17+6,500→ 6,500 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−6,500→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17+5,607→ 5,607 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−5,607→ 0 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    2,002,298

  • Common Stock

    (indirect: See Footnotes)
    12,438

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Ventures VI GP-GP, LLC
10% Owner
Transactions
  • Other

    Common Stock

    2021-02-17−325,000→ 2,236,888 total
  • Other

    Common Stock

    2021-02-17+6,500→ 6,500 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−6,500→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17+5,607→ 5,607 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−5,607→ 0 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    2,002,298

  • Common Stock

    (indirect: See Footnotes)
    12,438

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Vantage I, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-02-17−325,000→ 2,236,888 total
  • Other

    Common Stock

    2021-02-17+6,500→ 6,500 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−6,500→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17+5,607→ 5,607 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−5,607→ 0 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    2,002,298

  • Common Stock

    (indirect: See Footnotes)
    12,438

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Vantage I GP, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-02-17−325,000→ 2,236,888 total
  • Other

    Common Stock

    2021-02-17+6,500→ 6,500 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−6,500→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17+5,607→ 5,607 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−5,607→ 0 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    2,002,298

  • Common Stock

    (indirect: See Footnotes)
    12,438

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Versant Vantage I GP-GP, LLC
10% Owner
Transactions
  • Other

    Common Stock

    2021-02-17−325,000→ 2,236,888 total
  • Other

    Common Stock

    2021-02-17+6,500→ 6,500 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−6,500→ 0 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17+5,607→ 5,607 total(indirect: See Footnotes)
  • Other

    Common Stock

    2021-02-17−5,607→ 0 total(indirect: See Footnotes)
Holdings

  • Common Stock

    (indirect: See Footnotes)
    2,002,298

  • Common Stock

    (indirect: See Footnotes)
    12,438

  • Common Stock

    (indirect: See Footnotes)
    1,003,658
Footnotes (11)
  • [F1]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. ("Versant VI") to its partners pursuant to a Rule 10b5-1 trading plan.
  • [F10]Shares held by Versant Side Fund IV, L.P. ("Versant Side Fund IV"). Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports.
  • [F11]Shares held by Versant Vantage I, L.P. ("Versant Vantage"). Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("Versant Vantage I GP") and Versant Vantage I GP is the sole general Partner of Versant Vantage. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage. Each of Versant Vantage I GP-GP, Versant Vantage I GP, and Clare Ozawa disclaims beneficial ownership of the shares held by Versant Vantage, except to the extent of their respective pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports.
  • [F2]Shares held by Versant VI. Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the sole general partner of Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") and Versant Ventures VI GP is the sole general partner of Versant VI. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP and Clare Ozawa disclaims beneficial ownership of the shares held by Versant VI, except to the extent of their respective pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports.
  • [F3]Represents a change in the form of ownership of Versant Ventures VI GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant VI.
  • [F4]Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the sole general partner of Versant Ventures VI GP. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP. Each of Versant Ventures VI GP-GP and Clare Ozawa disclaims beneficial ownership of the shares held by Versant Ventures VI GP, except to the extent of their respective pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports.
  • [F5]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP, to its partners.
  • [F6]Represents a change in the form of ownership of Versant Ventures VI GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VI GP.
  • [F7]Shares held by Versant Ventures VI GP-GP. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP-GP; however, she disclaims beneficial ownership of such securities, except to the extent of her pecuniary interest therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports.
  • [F8]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP-GP, to its members.
  • [F9]Shares held by Versant Venture Capital IV, L.P. ("Versant IV"). Versant Ventures IV, LLC ("Versant Ventures IV") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports.

Documents

1 file

Issuer

Oyster Point Pharma, Inc.

CIK 0001720725

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001456591

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:16 PM ET
Size
32.8 KB
View on SEC.gov